S&P 500   3,475.02 (+1.40%)
DOW   28,560.85 (+1.30%)
QQQ   287.06 (+1.15%)
AAPL   118.93 (+2.54%)
MSFT   216.72 (+1.17%)
FB   269.63 (+3.15%)
GOOGL   1,566.99 (+2.42%)
AMZN   3,263.93 (+1.77%)
TSLA   425.80 (-1.17%)
NVDA   549.69 (+1.81%)
BABA   311.43 (+2.01%)
CGC   19.18 (-3.18%)
GE   7.38 (+1.23%)
MU   54.15 (+2.89%)
AMD   82.51 (+0.62%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.52 (-4.03%)
GILD   60.40 (-0.28%)
NFLX   532.34 (+0.31%)
BA   168.31 (+0.72%)
BAC   24.44 (+3.04%)
DIS   125.25 (+0.82%)
S&P 500   3,475.02 (+1.40%)
DOW   28,560.85 (+1.30%)
QQQ   287.06 (+1.15%)
AAPL   118.93 (+2.54%)
MSFT   216.72 (+1.17%)
FB   269.63 (+3.15%)
GOOGL   1,566.99 (+2.42%)
AMZN   3,263.93 (+1.77%)
TSLA   425.80 (-1.17%)
NVDA   549.69 (+1.81%)
BABA   311.43 (+2.01%)
CGC   19.18 (-3.18%)
GE   7.38 (+1.23%)
MU   54.15 (+2.89%)
AMD   82.51 (+0.62%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.52 (-4.03%)
GILD   60.40 (-0.28%)
NFLX   532.34 (+0.31%)
BA   168.31 (+0.72%)
BAC   24.44 (+3.04%)
DIS   125.25 (+0.82%)
S&P 500   3,475.02 (+1.40%)
DOW   28,560.85 (+1.30%)
QQQ   287.06 (+1.15%)
AAPL   118.93 (+2.54%)
MSFT   216.72 (+1.17%)
FB   269.63 (+3.15%)
GOOGL   1,566.99 (+2.42%)
AMZN   3,263.93 (+1.77%)
TSLA   425.80 (-1.17%)
NVDA   549.69 (+1.81%)
BABA   311.43 (+2.01%)
CGC   19.18 (-3.18%)
GE   7.38 (+1.23%)
MU   54.15 (+2.89%)
AMD   82.51 (+0.62%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.52 (-4.03%)
GILD   60.40 (-0.28%)
NFLX   532.34 (+0.31%)
BA   168.31 (+0.72%)
BAC   24.44 (+3.04%)
DIS   125.25 (+0.82%)
S&P 500   3,475.02 (+1.40%)
DOW   28,560.85 (+1.30%)
QQQ   287.06 (+1.15%)
AAPL   118.93 (+2.54%)
MSFT   216.72 (+1.17%)
FB   269.63 (+3.15%)
GOOGL   1,566.99 (+2.42%)
AMZN   3,263.93 (+1.77%)
TSLA   425.80 (-1.17%)
NVDA   549.69 (+1.81%)
BABA   311.43 (+2.01%)
CGC   19.18 (-3.18%)
GE   7.38 (+1.23%)
MU   54.15 (+2.89%)
AMD   82.51 (+0.62%)
T   26.94 (+0.22%)
F   7.84 (+3.29%)
ACB   4.52 (-4.03%)
GILD   60.40 (-0.28%)
NFLX   532.34 (+0.31%)
BA   168.31 (+0.72%)
BAC   24.44 (+3.04%)
DIS   125.25 (+0.82%)
Log in
NYSE:ALC

Alcon Stock Forecast, Price & News

$61.24
-0.19 (-0.31 %)
(As of 10/20/2020 01:39 PM ET)
Add
Compare
Today's Range
$60.83
Now: $61.24
$61.52
50-Day Range
$55.23
MA: $57.99
$62.58
52-Week Range
$39.37
Now: $61.24
$65.37
Volume12,187 shs
Average Volume1.32 million shs
Market Capitalization$29.90 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.51
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients. It operates through two segments, Surgical and Vision Care. The Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures, such as cataracts, vitreoretinal, refractive laser, and glaucoma surgery. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR ophthalmic microscope, verion imaged guided system, and ORA System for intra-operative measurements and guidance; vitreoretinal products comprising constellation vision system, grieshaber DSP and MIVS instrumentation, ultravit high speed vitrectomy probes, purepoint laser, and NGENUITY 3D visualization system; refractive surgery products, including WaveLight lasers and diagnostics used for LASIK; and glaucoma product, such as EX-PRESS glaucoma filtration device, as well as AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. The Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers under the TOTAL, PRECISION, Dailies, Air Optix, Systane, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.28 out of 5 stars

Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP04544X30
Phone41-58-911-2000
Employees22,142

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.51 billion
Cash Flow$4.83 per share
Book Value$39.54 per share

Profitability

Net Income$-656,000,000.00

Miscellaneous

Market Cap$29.90 billion
Next Earnings Date11/10/2020 (Confirmed)
OptionableNot Optionable
$61.24
-0.19 (-0.31 %)
(As of 10/20/2020 01:39 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALC News and Ratings via Email

Sign-up to receive the latest news and ratings for ALC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Alcon (NYSE:ALC) Frequently Asked Questions

How has Alcon's stock been impacted by Coronavirus (COVID-19)?

Alcon's stock was trading at $54.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ALC shares have increased by 13.0% and is now trading at $61.24.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Alcon?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last year. There are currently 4 sell ratings, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Alcon
.

When is Alcon's next earnings date?

Alcon is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Alcon
.

How can I listen to Alcon's earnings call?

Alcon will be holding an earnings conference call on Tuesday, November 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Alcon's earnings last quarter?

Alcon Inc. (NYSE:ALC) released its earnings results on Tuesday, August, 18th. The healthcare company reported ($0.21) EPS for the quarter, missing the Zacks' consensus estimate of ($0.15) by $0.06. The healthcare company had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.21 billion. Alcon had a positive return on equity of 2.94% and a negative net margin of 9.30%. The business's revenue was down 35.7% compared to the same quarter last year.
View Alcon's earnings history
.

What price target have analysts set for ALC?

17 brokers have issued twelve-month price targets for Alcon's shares. Their forecasts range from $50.00 to $68.00. On average, they expect Alcon's share price to reach $59.78 in the next year. This suggests that the stock has a possible downside of 2.4%.
View analysts' price targets for Alcon
.

Are investors shorting Alcon?

Alcon saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 5,620,000 shares, a decrease of 16.4% from the August 31st total of 6,720,000 shares. Based on an average daily trading volume, of 1,280,000 shares, the days-to-cover ratio is currently 4.4 days. Approximately 1.2% of the shares of the stock are short sold.
View Alcon's Short Interest
.

Who are some of Alcon's key competitors?

What other stocks do shareholders of Alcon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcon investors own include AT&T (T), Novartis (NVS), Verizon Communications (VZ), International Business Machines (IBM), Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Exxon Mobil (XOM) and AbbVie (ABBV).

Who are Alcon's key executives?

Alcon's management team includes the following people:
  • Mr. David J. Endicott, CEO & Director (Age 55, Pay $4.08M)
  • Mr. Timothy C. Stonesifer, Sr. VP & CFO (Age 53)
  • Margaret Buckley, Chief Accounting Officer
  • Ms. Sue-Jean Lin, Sr. VP & Chief Information Officer
  • Ms. Karen King, Sr. VP and Head of Global Investor Relations & Communications

What is Alcon's stock symbol?

Alcon trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALC."

Who are Alcon's major shareholders?

Alcon's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.22%), Exane Asset Management (0.18%), Capital Investment Services of America Inc. (0.05%), Martin Investment Management LLC (0.04%), Lathrop Investment Management Corp (0.03%) and Crossmark Global Holdings Inc. (0.01%).

Which institutional investors are selling Alcon stock?

ALC stock was sold by a variety of institutional investors in the last quarter, including Douglas Lane & Associates LLC, Clean Yield Group, Park National Corp OH, CWM LLC, Crossmark Global Holdings Inc., Ipswich Investment Management Co. Inc., Norman Fields Gottscho Capital Management LLC, and MADDEN SECURITIES Corp.

Which institutional investors are buying Alcon stock?

ALC stock was purchased by a variety of institutional investors in the last quarter, including Exane Asset Management, Capital Investment Services of America Inc., Envestnet Asset Management Inc., Martin Investment Management LLC, Lathrop Investment Management Corp, Gofen & Glossberg LLC IL, Chesley Taft & Associates LLC, and Arden Trust Co.

How do I buy shares of Alcon?

Shares of ALC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Alcon's stock price today?

One share of ALC stock can currently be purchased for approximately $61.24.

How big of a company is Alcon?

Alcon has a market capitalization of $29.90 billion and generates $7.51 billion in revenue each year. The healthcare company earns $-656,000,000.00 in net income (profit) each year or $1.89 on an earnings per share basis. Alcon employs 22,142 workers across the globe.

What is Alcon's official website?

The official website for Alcon is www.alcon.com.

How can I contact Alcon?

Alcon's mailing address is Rue Louis-d`Affry 6, Fribourg V8, 1701. The healthcare company can be reached via phone at 41-58-911-2000 or via email at [email protected]

This page was last updated on 10/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.